Talking Euretina
Podcast tekijän mukaan Whipsmart Media
60 Jaksot
-
Episode 39: The Euretina Retinal Medicine Clinical Research Award
Julkaistiin: 15.11.2023 -
Episode 38: Preview of Euretina Congress 2023
Julkaistiin: 29.9.2023 -
Episode 37: Blind Faith - How RP patients are being targeted with bad science across the world
Julkaistiin: 15.9.2023 -
Episode 36: The Ophthalmologica Lecture: Maximilian Pfau
Julkaistiin: 1.9.2023 -
Episode 35: Treating PCV and Pachychoroid in Different Populations
Julkaistiin: 15.8.2023 -
Episode 34: The Euretina Lecture: OncoVR
Julkaistiin: 31.7.2023 -
Episode 33: The Euretina Innovation Summit - All You Need to Know
Julkaistiin: 3.7.2023 -
Episode 32: Macular Holes and Glaucoma in Myopia
Julkaistiin: 15.6.2023 -
Episode 31: Featured studies from the Ophthalmologica journal
Julkaistiin: 18.5.2023 -
Episode 30: Intraocular Lymphoma: An Explainer
Julkaistiin: 2.5.2023 -
Episode 29: How to get published in Euretina’s Journal, Ophthalmologica
Julkaistiin: 14.4.2023 -
Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world
Julkaistiin: 30.3.2023 -
Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?
Julkaistiin: 14.3.2023 -
Episode 26: Tackling Acute Retinal Necrosis in Patients
Julkaistiin: 1.3.2023 -
Episode 25: What individual patient data can tell us about treating macular holes
Julkaistiin: 15.2.2023 -
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
Julkaistiin: 6.2.2023 -
Episode 23: Everything You Need to Know About the New EBO-Euretina Exam
Julkaistiin: 17.1.2023 -
Episode 22: Women in Retina
Julkaistiin: 1.12.2022 -
Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma
Julkaistiin: 17.11.2022 -
Episode 20: A Deep Dive into the MOLES System
Julkaistiin: 3.11.2022
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.
